TRANSLATING CLINICAL EVIDENCE FOR SENSOR-BASED GLUCOSE MONITORING AND TECHNOLOGICAL INNOVATIONS TO THE FRONT LINES OF CLINICAL PRACTICE
Course Description:In this web-based program, physicians will learn how recent developments in sensor-based continuous glucose monitoring have advanced the management of Type 1 and Type 2 diabetes.
- Outline and discuss the evidentiary basis for senor/patch-based CGM technologies, and how to best Implement CGM-based technologies into their overall diabetes care plans for patients with T1D and T2D.
- Analyze the rationale and evidence for recommending and facilitating adoption of technology-centric CGM monitoring and treatment plans using patch-and-reader-based technologies.
- Compare and contrast available CGM-facilitating monitoring technologies and pair such technologies with optimal patient profiles.
- Educate patients with diabetes about the rationale, evidence, and outcome- optimizing results associated with technology-based, patient-centric and physician-directed CGM monitoring strategies that can be used to effect optimal lifestyle, diet-, and pharmacology-based approaches to attaining guideline-based HA1c levels in patients with T1d and T2D.
- Identify which patients with diabetes are ideal candidates for a technology-based, patient-directed glucose monitoring system.
- Interpret and apply data and results from clinical trials and experts with experience in CGM-facilitating monitoring technologies to improve patient care, improve safety of drug therapy for T1D and T2D, detect and mitigate risk of hypoglycemia, improve patient- and physician-directed changes in antidiabetic therapy, reinforce the safe use of antidiabetic drugs, and facilitate patient-activated drug titration, glycemic monitoring and disease management.
- Translate landmark clinical studies focused on CGM-based technologies to the front lines of clinical practice in the diabetes and primary care setting; and understand the translational implications of deploying sensor-based, CGM-based technologies as a foundational approach to improving outcomes in patients across the spectrum of diabetes.
- Educate other clinical providers on the diabetes care team about the rationale, role, evidence, and outcome-enhancing results that are derived from employing technology-based CGM strategies—both patient- and physician-directed—across the broad spectrum of patients with diabetes.
Course Instructor Bio(s)
James R. Gavin III, MD, PhD
Healing Our Village, Inc.
Clinical Professor of Medicine
Emory University School of Medicine
Irl Hirsch, MD
University of Washington Medical Center
UWMC Diabetes Care Center
Seattle, Washington, USA
Consultant: Abbott Diabetes Care, Bigfoot, Roche
Eden Miller, DO
High Lakes Health Care
St. Charles Hospital
Bend, Oregon, USA
Richard Bergenstal, MD
International Diabetes Center- Park Nicollet
Minneapolis, MN, United States
attended a live program?
FREQUENTLY ASKED QUESTIONS
continuing medical education courses
Earn CME credits at no cost to you.